A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

MilliporeSigma opens two new mRNA drug substance manufacturing sites in Germany; the firm is first contract testing, development, and manufacturing company with integrated services for all stages of mRNA development, manufacturing, and commercialization

Merck KGaA’s MilliporeSigma expands its global mRNA network with two new drug substance manufacturing sites in Darmstadt and Hamburg, Germany; the facilities to support all stages of mRNA development and commercialization

Merck wraps up first four years of SMASH Packaging, a global approach based on four pillars--SHRINK, SECURE, SWITCH and SAVE; since SMASH Packaging’s inception, over 100 packaging improvement projects have been completed or are underway

Novo Nordisk, Lilly, Sanofi, Merck KGaA partner to recycle 25% of the 6 million insulin pens they sell in Denmark; the initiative aims to reclaim around 25 tons of plastic from the pens; 60% of which is high-quality plastic

Merck KGaA regains worldwide rights to cancer immunotherapy Bavencio, ending collaboration with Pfizer; 15% royalty on net sales to be paid to Pfizer.

Ask us about our Chemicals Industry market view

Trending Chart

Interactive chart with headline count